NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00641-6022-25 — Famotidine injection, 20 mg per 2 mL IVAI (562 hospitals, 947,774–949,241 samples)
• NDC 00990-7922-09 — Dextrose 5% intravenous solutionAI (426 hospitals, 934,664–934,970 samples)
• NDC 00990-7941-09 — Dextrose and saline intravenous fluidAI (401 hospitals, 914,484–915,231 samples)
• NDC 67386-0130-51 — Vyepti 100 mg/mL intravenous solutionAI (971 hospitals, 850,986–852,129 samples)
• NDC 00338-0085-04 — Dextrose 5% and half-strength saline IV solutionAI (805 hospitals, 824,948–829,223 samples)
• NDC 00517-2310-05 — Venofer (iron sucrose) iron infusion solutionAI (639 hospitals, 814,293–815,922 samples)
• NDC 16729-0267-65 — Docetaxel 160 mg/8 mL intravenous concentrateAI (357 hospitals, 802,825–803,158 samples)
• NDC 00054-8175-25 — Dexamethasone 4 mg tabletAI (905 hospitals, 779,870–785,882 samples)
• NDC 00338-0691-04 — Potassium chloride in saline IV solutionAI (784 hospitals, 773,383–775,867 samples)
• NDC 00338-0017-04 — Dextrose 5% intravenous solutionAI (857 hospitals, 735,069–736,887 samples)
• NDC 00009-0417-01 — Testosterone cypionate 200 mg/mL injectionAI (561 hospitals, 679,799–679,844 samples)
• NDC 00264-7800-00 — Sodium chloride 0.9% IV fluid bagAI (527 hospitals, 651,901–662,953 samples)
• NDC 00409-3177-01 — Lidocaine with epinephrine injectionAI (576 hospitals, 649,046–654,239 samples)
• NDC 63323-0483-27 — Lidocaine with epinephrine injectionAI (945 hospitals, 621,721–628,489 samples)
• NDC 00944-2884-01 — Alpha-1 proteinase inhibitor IV solutionAI (307 hospitals, 628,116 samples)
• NDC 17271-0701-03 — Sodium chloride 0.9% IV solutionAI (123 hospitals, 621,060–621,555 samples)
• NDC 65219-0220-01 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (7 hospitals, 600,776 samples)
• NDC 00338-0125-04 — Dextrose and lactated Ringer's IV solutionAI (830 hospitals, 593,967–595,488 samples)
• NDC 63459-0348-04 — Bendeka bendamustine IV infusion solutionAI (1115 hospitals, 590,565–590,871 samples)
• NDC 00409-0152-24 — Metronidazole 500 mg IV infusionAI (590 hospitals, 554,384–555,167 samples)
• NDC 00409-1559-10 — Marcaine preservative-free numbing injection 0.25%AI (359 hospitals, 537,299–539,441 samples)
• NDC 00270-1316-35 — Isovue-370 iodinated contrast injectionAI (653 hospitals, 511,588–525,592 samples)
• NDC 00270-7025-40 — Vueway contrast dye for IV injectionAI (226 hospitals, 519,667–520,333 samples)
• NDC 00019-0953-05 — Iothalamate meglumine 60% injectable contrast solutionAI (248 hospitals, 515,499–515,688 samples)
• NDC 50242-0245-01 — Phesgo subcutaneous injection, pertuzumab and trastuzumab combinationAI (649 hospitals, 486,381–486,741 samples)
• NDC 00338-0017-02 — Dextrose 5% intravenous solutionAI (760 hospitals, 480,758–483,485 samples)
• NDC 63323-0492-27 — Lidocaine numbing injection, 1% solution, 2 mL vialAI (887 hospitals, 457,217–472,490 samples)
• NDC 63323-0269-65 — Diprivan (propofol) IV anesthesia emulsion, 100 mLAI (1129 hospitals, 459,245–466,328 samples)
• NDC 00409-4278-01 — Lidocaine hydrochloride 0.5% injectionAI (626 hospitals, 450,535–453,280 samples)
• NDC 55513-0207-01 — Mvasi (bevacizumab) 400 mg IV infusion vialAI (1007 hospitals, 451,890–452,520 samples)
• NDC 63323-0465-57 — Sensorcaine (bupivacaine) 0.25% numbing injectionAI (435 hospitals, 434,757–441,192 samples)
• NDC 00143-9328-10 — Bupivacaine 0.25% injectionAI (185 hospitals, 420,328–421,849 samples)
• NDC 00990-7941-03 — Dextrose and saline intravenous solutionAI (123 hospitals, 410,013–410,175 samples)
• NDC 55150-0249-50 — Bupivacaine 0.25% injection solutionAI (456 hospitals, 402,318–407,664 samples)
• NDC 00264-7800-10 — Sodium chloride 0.9% IV solutionAI (671 hospitals, 393,625–403,030 samples)
• NDC 00990-7902-09 — Potassium chloride in dextrose and sodium chloride IV solutionAI (471 hospitals, 401,226–402,432 samples)
• NDC 71288-0723-52 — Bupivacaine 0.25% numbing injection solutionAI (86 hospitals, 396,116–397,493 samples)
• NDC 70069-0752-01 — Bupivacaine 0.25% injection (local numbing medicine)AI (36 hospitals, 394,452–394,650 samples)
• NDC 72603-0279-01 — Bupivacaine 0.25% numbing injectionAI (16 hospitals, 393,892–393,901 samples)
• NDC 63323-0486-27 — Lidocaine 2% injection solutionAI (781 hospitals, 385,967–389,819 samples)
• NDC 63323-0486-57 — Xylocaine 2% injection solutionAI (455 hospitals, 380,483–382,859 samples)
• NDC 00409-4277-02 — Lidocaine 2% injection solutionAI (439 hospitals, 377,577–382,653 samples)
• NDC 63323-0486-05 — Lidocaine 2% injection solutionAI (161 hospitals, 378,179–380,141 samples)
• NDC 17271-0710-07 — Lactated Ringer's intravenous solution, 1 literAI (125 hospitals, 371,471–373,235 samples)
• NDC 00409-4282-02 — Lidocaine HCl 2% injection solutionAI (581 hospitals, 367,635–372,927 samples)
• NDC 00409-4283-01 — Lidocaine 4% injection solutionAI (823 hospitals, 354,997–363,070 samples)
• NDC 00409-1323-05 — Lidocaine heart-rhythm injection, 100 mg per 5 mL syringeAI (708 hospitals, 349,113–352,632 samples)
• NDC 00407-1413-63 — Omnipaque 300 contrast injectionAI (659 hospitals, 317,054–321,887 samples)
• NDC 00270-7030-42 — Vueway MRI contrast agent for IV injection, 0.5 mmol/mLAI (241 hospitals, 310,180–310,738 samples)
• NDC 00270-1316-95 — Isovue-370 iodinated contrast injectionAI (324 hospitals, 293,271–307,851 samples)